19
total announcements
544709.BO · 15 min delayed
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced the completion of dispatch of notice for its 11th Annual General Meeting (AGM) and E-Voting information, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has dispatched physical letters to members whose email addresses are not registered with the company, registrar, or depository participants, containing the web-link and navigation path to access the Annual Report for the Financial Year 2025-26.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced its Annual Report for the Financial Year 2025-26, which includes details of its 11th Annual General Meeting, financial statements, and corporate overview.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced the notice of its 11th Annual General Meeting (AGM) to be held on September 28, 2026, through video conferencing. The meeting will consider and adopt the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and re-appoint Mr. Vishad Khanna as a director.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has informed the exchange about the publication of a newspaper advertisement regarding the Pre-AGM Notice of its 11th Annual General Meeting to be held on September 28, 2026, through Video Conferencing/Other Audio Visual Means.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue growing 9.1% YoY to ₹19.4 crores, and reported EBITDA and PAT at ₹2.4 crores and ₹1.8 crores respectively.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has informed the Exchange about the audio recording of the Earnings Call on the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in accordance with Regulation 33 read with Regulation 47(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has revised its investor presentation for Q1 FY27, incorporating corrections and additional disclosures related to its financial results.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has released an investor presentation for Q1 FY27, highlighting its financial results and business updates.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced the Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations and Monitoring Agency Agreement. The report indicates no deviation from the objects of the Initial Public Offer (IPO) and no range of deviation from the amount of issue proceeds earmarked for objects.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd reported Q1FY27 revenue of ₹19.4 Cr, a 9.13% YoY growth, with EBITDA at ₹2.4 Cr and PAT at ₹1.8 Cr. The company commenced operations at its new IVF Centre/Hub at South Extension, New Delhi, and approved the establishment of 'Gaudium Women Hospital, Lucknow'.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the Limited Review Report from the Statutory Auditors. The company has also approved the Re-appointment of Ram Rattan & Associates as the Internal Auditor and the appointment of Suresh Nainwal & Company as a Secretarial Auditor. Additionally, the company has disclosed the statement of Deviation(s) or Variation(s) regarding the utilization of funds raised through Initial Public Offer (IPO) for the quarter ended June 30, 2026.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced the appointment of a secretarial auditor for a term of 5 years, subject to shareholder approval, and has also approved the unaudited financial results for the quarter ended June 30, 2026, and other matters.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced the appointment of Internal Auditor, Re-appointment of Internal Auditor, and appointment of Secretarial Auditor. The company has also approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company's board has approved the re-appointment of Ram Rattan & Associates as the Internal Auditor for the Financial Year 2026-27. Additionally, the board has approved the appointment of M/s. Suresh Nainwal & Company as a Secretarial Auditor for a term of 5 years. The company has also scheduled its 11th Annual General Meeting for September 28, 2026, through video conferencing.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has approved the re-appointment of its internal auditor and the appointment of a secretarial auditor.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has scheduled an earnings conference call to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The call is scheduled for August 14, 2026, at 2:00 P.M. IST. The company has provided details of the call, including a pre-registration link and international toll-free numbers.
Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd has scheduled a Board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.